By Dr. Jim Li, CEO, Sundia MediTech Company, Ltd
Since 2015, Chinese NMPA has carried out a series reforms in drug approval process and produced a number of policies, such as requirement of GCE (Generics Consistency Evaluation) in...
By Bill Humphries, President, Merz North America Inc.
As the North American CEO of a global pharmaceutical company, I constantly face challenges that all CEOs face, with the additional challenge of dealing with an evolving regulatory landscape.
By Blythe Lawton, Senior Director, First Associates Loan Servicing
Using Artificial Intelligence to record every call and interaction offers the necessary customer insight to improve key service areas.
By Yulia Kogan, Director of Information Technology, Northwell Health
In oncology, genomic science is used to identify tumor mutations, which helps to guide treatment strategies, leading to higher efficacy.
By Mark Behlke, CSO, Integrated DNA Technologies
Functional genomics is the discipline that investigates function of genes through use of synthetic oligonucleotides or longer nucleic acids in living cells in ways that alter the genome or changes gene expression.
By Dr. Chris Stout, VP, Research and Data Analytics, ATI
Much of the world is focused on the latest sizzle of big data, artificial intelligence, internet-of-things, augmented reality and machine learning.
By Mark Hoffman, Chief Research Information Officer, Children’s Mercy Hospital
We need to approach the relationship with vendors as a partnership rather than a zero-sum game.
By Karl Rosenblum, Head, Global Capacity and Risk Strategy, Alcon
This is an exciting time for the manufacturing industry. It's tempting to think of the future as far off. But, actually it is already here, it's just unevenly distributed.
By Jonathan Shough, CIO, INC Research
With increasing opportunities being presented to us through our rapid IT growth, we have become better equipped to examine our work processes. IT plays such an integral part of our overall work that we recognize its impact on our ability.